Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Amgen Inc (NASDAQ:AMGN)

173.14
Delayed Data
As of 4:00pm ET
 -0.15 / -0.09%
Today’s Change
133.64
Today|||52-Week Range
176.85
+18.42%
Year-to-Date
Top Research Reports for Amgen, Bank of America, and Proctor & Gamble
9:41am / Zacks.com - Paid Partner Content
Two Sigma Advisers, Llc Buys Cisco Systems, Medtronic PLC, Oracle, Sells Amazon. ...
Feb 15 / GuruFocus News - Paid Partner Content
Study Reveals PCSK9 Drugs Can Save Heart Disease Patients
8:21am / MotleyFool.com - Paid Partner Content
3 Beaten-Down Stocks Ready to Bounce Back
Feb 10 / MotleyFool.com - Paid Partner Content
The Four Key Themes From Q4 Conference Calls
Feb 17 / Investing Channel - Paid Partner Content
Biotech ETFs Powered by Q4 Earnings
Feb 10 / Zacks.com - Paid Partner Content
Mylan's Proposed Biosimailar for Cancer Under Review in U.S.
Feb 17 / Zacks.com - Paid Partner Content
Regeneron (REGN) Misses on Q4 Earnings & Sales, View Bleak
Feb 09 / Zacks.com - Paid Partner Content
Valeant's (VRX) Plaque Psoriasis Drug Approved in the U.S.
Feb 17 / Zacks.com - Paid Partner Content
Regeneron (REGN) Q4 Earnings: Will the Stock Disappoint?
Feb 08 / Zacks.com - Paid Partner Content
Pfizer's Xeljanz Combo Comparable to AbbVie's Humira
Feb 17 / Zacks.com - Paid Partner Content
Why Coherus Biosciences Is Falling Today
Feb 08 / MotleyFool.com - Paid Partner Content
Don't Count on Valeant's New Drug to Save the Day
Feb 16 / MotleyFool.com - Paid Partner Content
Allergan (AGN) Tops Q4 Earnings; 2017 Sales View Upbeat
Feb 08 / Zacks.com - Paid Partner Content
Marco Investment Management Llc Buys Johnson Controls International PLC, Amgen, AbbVi...
Feb 16 / GuruFocus News - Paid Partner Content
Amgen's Secondary Hyperparathyroidism Drug Approved in U.S.
Feb 08 / Zacks.com - Paid Partner Content
Amgen Shows a Bullish Breakout
Feb 16 / TheStreet.com - Paid Partner Content
Better Buy: Amgen Inc. vs. Celgene
Feb 08 / MotleyFool.com - Paid Partner Content
Health Care ETF Has Been Ailing
Feb 16 / TheStreet.com - Paid Partner Content
Biotech Stock Roundup: Amgen, Gilead Report 4Q Results, ARIAD Seeks EU Nod for Brigat...
Feb 08 / Zacks.com - Paid Partner Content
Alzheimer's Market Suffers Yet Another Blow with Merck Drug Setback
Feb 16 / Zacks.com - Paid Partner Content
Drug Stock Q4 Earnings to Watch on Feb 8: AGN, GSK & More
Feb 07 / Zacks.com - Paid Partner Content
Samlyn Capital, Llc Buys TD Ameritrade Holding, American Express Co, Comerica, Sells ...
Feb 15 / GuruFocus News - Paid Partner Content
Pharma stocks rally on Trump pledge to speed drug approvals
Feb 02 / FT.com - Paid Partner Content
Want to Get In on Biotech? Check Out These 3 Stocks
Feb 15 / MotleyFool.com - Paid Partner Content
CEOs cheat sheet on how to please Trump
Jan 31 / CNNMoney.com
Amgen Looking to Broaden Leukemia Drug Blincyto's Label
Feb 15 / Zacks.com - Paid Partner Content